CDRH: EMERGING CANCER BLOOD TEST CONCERNS BEYOND FDA'S AUTHORITY

Press/Media

Period7 Dec 2023

Media coverage

1

Media coverage

  • TitleCDRH: EMERGING CANCER BLOOD TEST CONCERNS BEYOND FDA'S AUTHORITY
    Media name/outletInside CMS
    Country/TerritoryUnited States
    Date7/12/23
    PersonsMary Kemeny